INS and Alzheimer disease: Hyperinsulinemia—as a result of insulin signaling dysfunction, oxidative stress in cells, and hypercholesterolemia—accelerates the production and accumulation of abnormally folded proteins in the brain, such as amyloid-β and tau protein, which have been confirmed to play a major role in the pathophysiology of AD.